Search results
Moderna says its combination Covid and flu vaccine works well in late-stage trial
NBC NEWS· 3 days agoModerna said on Monday its combination vaccine to protect against both Covid and influenza generated...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 7 days agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 2 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoA combined flu and Covid vaccine from Moderna has been found to provoke a higher immune response...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 3 days agoModerna said its combination flu and Covid shot met the goals of a pivotal late-stage trial,...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 3 days agoModerna compared the immune response between those who were given mRNA-1083 versus those who were...
3 Reasons to Buy Moderna Stock | The Motley Fool
The Motley Fool· 5 days agoAlthough Moderna (MRNA -2.38%) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Is Moderna just...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 6 days agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval